ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 123 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,069,177 | +1586.4% | 149,789 | +1210.4% | 0.01% | +1100.0% |
| Q3 2022 | $182,000 | +4.0% | 11,431 | -10.2% | 0.00% | 0.0% |
| Q2 2022 | $175,000 | -12.1% | 12,731 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $199,000 | -24.9% | 12,551 | +3.3% | 0.00% | 0.0% |
| Q4 2021 | $265,000 | -27.6% | 12,151 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $366,000 | -34.4% | 12,251 | -2.8% | 0.00% | -50.0% |
| Q2 2021 | $558,000 | -13.4% | 12,601 | -13.1% | 0.00% | 0.0% |
| Q1 2021 | $644,000 | -36.7% | 14,506 | -21.9% | 0.00% | -50.0% |
| Q4 2020 | $1,018,000 | +14.1% | 18,566 | -52.4% | 0.00% | 0.0% |
| Q3 2020 | $892,000 | +9.9% | 39,004 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $812,000 | +66.4% | 38,783 | +10.8% | 0.00% | +33.3% |
| Q1 2020 | $488,000 | -75.3% | 34,992 | -59.8% | 0.00% | -70.0% |
| Q4 2019 | $1,979,000 | – | 86,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |